RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Molecular Data Stock

Molecular Data ROE 2024

Molecular Data ROE

0

Ticker

MKD

ISIN

US60852L1061

WKN

A2PYCA

In 2024, Molecular Data's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.

Molecular Data Aktienanalyse

What does Molecular Data do?

Molecular Data Inc. is a leading technology company specializing in the use of big data, artificial intelligence (AI), and blockchain technology in the chemical and pharmaceutical industry. The company was founded in 2014 and is headquartered in Shanghai, China. Molecular Data Inc. has a comprehensive database consisting of millions of chemical compounds, which aids chemists, pharmaceutical companies, and researchers in identifying, exploring, and developing new drugs. The company places great importance on integrating data and technologies to accelerate and improve drug development. Molecular Data Inc. provides cloud-based solutions based on the analysis of big data through AI algorithms and blockchain technology. It offers platforms, as well as consulting and training services, to support customers in efficiently utilizing the platforms. The company's main products include the MDL platform, which enables the integration of data, knowledge, and algorithms to accelerate drug development processes. The MDL platform is a cloud-based system that provides access to a database of millions of compounds and allows users to receive real-time results. Molecular Data Inc. also offers a blockchain-based platform for the chemical and pharmaceutical industry, enhancing the transparency and security of data and information. The platform facilitates secure data exchange between different companies and regulatory authorities, providing improved control and monitoring of data. Another important service provided by Molecular Data Inc. is consulting and training for companies in implementing big data, AI, and blockchain into their workflows. The company aims to equip its customers with the necessary skills and knowledge to optimize their business processes and increase competitiveness. Molecular Data Inc. is divided into several divisions to ensure efficient collaboration and product development. These divisions include research and development, sales and marketing, finance and administration, and information technology. The company strives to expand its business through strategic partnerships and acquisitions. It has already completed several acquisitions to strengthen its expertise in big data, AI, and blockchain. Through these strategic measures, the company has been able to offer its customers a comprehensive range of products and services to enhance performance and increase competitiveness. Overall, Molecular Data Inc. is a significant company in the chemical and pharmaceutical industry that specializes in the integration of data and technologies to enhance process efficiency and speed. The company aims to strengthen its position as a market leader through innovation and strategic partnerships. Molecular Data ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Molecular Data's Return on Equity (ROE)

Molecular Data's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Molecular Data's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Molecular Data's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Molecular Data’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Molecular Data stock

What is the ROE (Return on Equity) of Molecular Data this year?

The ROE of Molecular Data this year is 0 undefined.

How has the Return on Equity (ROE) of Molecular Data developed compared to the previous year?

The ROE of Molecular Data has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Molecular Data?

A high ROE indicates that Molecular Data generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Molecular Data?

A low ROE can indicate that Molecular Data is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Molecular Data affect the company?

A change in ROE (Return on Equity) of Molecular Data can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Molecular Data?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Molecular Data?

Some factors that can influence Molecular Data's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Molecular Data pay?

Over the past 12 months, Molecular Data paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Molecular Data is expected to pay a dividend of 0 CNY.

What is the dividend yield of Molecular Data?

The current dividend yield of Molecular Data is .

When does Molecular Data pay dividends?

Molecular Data pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Molecular Data?

Molecular Data paid dividends every year for the past 0 years.

What is the dividend of Molecular Data?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Molecular Data located?

Molecular Data is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von Molecular Data kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Molecular Data from 9/9/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Molecular Data pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Molecular Data in the year 2023?

In the year 2023, Molecular Data distributed 0 CNY as dividends.

In which currency does Molecular Data pay out the dividend?

The dividends of Molecular Data are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Molecular Data

Our stock analysis for Molecular Data Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Molecular Data Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.